Stryker (NYSE:SYK) Hits New 1-Year Low – What’s Next?

Stryker Corporation (NYSE:SYK) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $283.36 and last traded at $284.4610, with a volume of 62515 shares. The stock had previously closed at $285.47.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SYK shares. William Blair reaffirmed an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Wells Fargo & Company reduced their target price on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Piper Sandler reaffirmed an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. Sanford C. Bernstein set a $410.00 price target on Stryker in a research note on Friday, May 1st. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $465.00 price target on shares of Stryker in a research note on Wednesday, March 4th. Sixteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and a consensus price target of $395.48.

Stryker Price Performance

The stock has a market capitalization of $108.48 billion, a price-to-earnings ratio of 32.79, a price-to-earnings-growth ratio of 1.80 and a beta of 0.80. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The company has a 50-day simple moving average of $340.37 and a two-hundred day simple moving average of $355.17.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. During the same period last year, the business earned $2.84 EPS. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s dividend payout ratio is currently 40.74%.

Institutional Investors Weigh In On Stryker

A number of large investors have recently added to or reduced their stakes in SYK. Wolff Wiese Magana LLC boosted its holdings in shares of Stryker by 2.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock valued at $470,000 after purchasing an additional 28 shares in the last quarter. VanderPol Investments L.L.C. boosted its holdings in shares of Stryker by 1.4% in the 4th quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company’s stock valued at $732,000 after purchasing an additional 28 shares in the last quarter. KCM Investment Advisors LLC boosted its holdings in shares of Stryker by 1.5% in the 4th quarter. KCM Investment Advisors LLC now owns 1,857 shares of the medical technology company’s stock valued at $653,000 after purchasing an additional 28 shares in the last quarter. Rossby Financial LCC lifted its stake in shares of Stryker by 6.6% in the 4th quarter. Rossby Financial LCC now owns 451 shares of the medical technology company’s stock valued at $159,000 after acquiring an additional 28 shares during the last quarter. Finally, Lantz Financial LLC boosted its stake in shares of Stryker by 5.0% in the 3rd quarter. Lantz Financial LLC now owns 608 shares of the medical technology company’s stock worth $225,000 after buying an additional 29 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.